In addition, another observational study (TRACK-MSA) in MSA patients is underway to define changes of CSF and plasma biomarkers, including α-synuclein, aggregated α-synuclein, Nfl and Tau/phosphorylated Tau in CSF, and plasma Nfl as well (NCT04450992). Here, MAPT is linked to multiple system atrophy.